Home » Topics » Regulatory » Patents

Patents
RSS

Novel class of immunosuppressants disclosed by Novartis

March 4, 1997

Cephalosporin antibiotics revealed by Microcide

March 4, 1997

TK inhibitors disclosed by Pfizer

March 4, 1997

Antiarrhythmic agents reported by National Science Council

March 4, 1997

Takeda describes antitumor agents

March 4, 1997

RCT discloses compounds for radiolabeling leukocytes/lymphocytes

March 4, 1997

Novel polyamines fromTeva

March 3, 1997

Novel antitumor agents disclosed by Yale University

March 3, 1997

Tokyo Tanabe claims antifungal agents

March 3, 1997

Symphar/SKB disclose compounds with Lp(a)-lowering activity

March 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 14, 2025.
European VCs optimistic for med-tech exit opportunities in 2025
BioWorld MedTech
To say that European investors are optimistic about the outlook for the med-tech sector in 2025 is an understatement. A couple of companies are already listed on...
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Feb. 14, 2025
European VCs bullish on med-tech investments in 2025
BioWorld MedTech
European companies looking for capital should find the fundraising environment more favorable in 2025. Private med-tech financings in January totaled about $2...
Kura/Kyowa Kirin’s ziftomenib hits phase II endpoints in AML
BioWorld
Kura Oncology Inc. and Kyowa Kirin Co. Ltd.’s selective oral menin inhibitor, ziftomenib, met the primary endpoints in the phase II registrational Komet-001 trial...